GlassScriptPhysician profile
Alison S Schultz
NPI 1730512187
$1,251.55
in general payments reported to CMS, 2019-2025
23 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $607 · 2023: $213 · 2024: $106 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $454.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $454.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $463.59 | 2021-2023 | Ozempic, Rybelsus, Wegovy |
| Rgh Enterprises LLC | $98.12 | 2025 | |
| Novartis Pharmaceuticals Corporation | $83.01 | 2021-2022 | |
| Dexcom, INC. | $73.21 | 2021-2024 | Dexcom G6 Transmitter |
| Abbott Laboratories | $72.78 | 2021-2025 | Pressurewire, Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.29 | 2023 | |
| Lilly USA, LLC | $36.25 | 2022-2023 | Trulicity, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $36.05 | 2021-2022 | |
| Pfizer INC. | $32.60 | 2022-2023 | |
| Medtronic, INC. | $26.70 | 2023 | Minimed 780g |
| Janssen Pharmaceuticals, INC | $25.69 | 2021 | |
| Sanofi-Aventis U.S. LLC | $25.11 | 2024 | |
| Ucb, INC. | $22.27 | 2021 | |
| Boston Scientific Corporation | $19.88 | 2025 | General - Pain Management |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $18.79 | 2021 | |
| Amarin Pharma, INC. | $17.19 | 2022 | |
| Exact Sciences Corporation | $16.78 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.45 | 2023 | Xifaxan |
| Horizon Therapeutics Plc | $15.24 | 2022 | |
| Amgen INC. | $14.48 | 2022 | |
| Merck Sharp & Dohme LLC | $13.18 | 2022 | |
| Abbvie INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.